Angeliki Andrikopoulou

14PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 21, 2026
A Prospective Study of Familial Predisposition in Plasma Cell Dyscrasias.

|Jan 30, 2026
The Hippo Pathway in Metaplastic Breast Carcinoma: Prognostic Significance and Therapeutic Implications.

Eleni Papamattheou, Alkistis Papatheodoridi, Ioannis Katsaros

|Nov 27, 2025
Epigenetics in Ovarian Cancer: A Review of Current Knowledge and Future Perspectives.

Nikolaos Dedes, Michalis Liontos, Dimitrios Haidopoulos

|Feb 13, 2025
Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer.

Stavroula A Paschou, Angeliki Andrikopoulou, Nikoletta Mili

|Jan 25, 2025
Long-Term Survivor with Paraneoplastic Cerebellar Ataxia and Small-Cell Lung Cancer.

Konstantinos Tsoukalas, Ioannis Ntanasis-Stathopoulos, Angeliki Andrikopoulou

|Jun 19, 2024
The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer.

Angeliki Andrikopoulou, Garyfalia Bletsa, Angeliki Rouvalis

Pageof 3

Frequent Collaborators

11 joint publications

Meletios-Athanasios Dimopoulos

10 joint publications

Michalis Liontos

5 joint publications

Evangelos Terpos

4 joint publications

Anna Svarna